Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sogeval is a French pharmaceutical company specializing in the development, manufacture, and marketing of veterinary medicines and animal health products. Founded in 1986 and headquartered in Laval, France, the company focuses on therapeutic areas such as dermatology, cardiology, and antibiotic therapy for companion animals and livestock. Sogeval is particularly recognized for its innovative delivery systems and leading brands like Douxo and Clavaseptin. In 2013, the company was acquired by Ceva Santé Animale, significantly expanding Ceva's portfolio in the companion animal sector. Today, Sogeval operates as a key subsidiary within the Ceva group, continuing to provide specialized veterinary solutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sogeval.